Fierce Healthcare July 23, 2024
Noah Tong

Lawmakers bashed the business practices of pharmacy benefit managers during a House Committee on Oversight and Accountability hearing Tuesday.

When they were asked repeatedly about steering patients, increased drug prices and pharmacy closures, the company executives largely refuted claims thrown at them.

Lawmakers were overwhelmingly frustrated with the perceived non-answers given and at one point reminded the leaders of Optum Rx, Express Scripts and CVS Caremark they were under oath. Witnesses at times were united in silence after lawmakers asked questions, knowing they would not provide an answer that would satisfy the members.

The hearing coincided with the release of a new report (PDF) compiled by the committee that found the three largest PBMs — which are vertically integrated with...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies, Pharma, Pharma / Biotech
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Trump tariffs could drive up generic drug costs: 5 takeaways
Bridging the Gap: Pharmacists' Role in Advancing Pharmacogenomic Testing Standards
The Evolving Role of Pharmacists in Custom Pathway Implementation
Pharma Pulse 11/25/24: Deepening Patient Relationships,

Share This Article